Clinical trial Recruiting at 1 site Observational Ages 18 and up

Using a new technique to repair large paraesophageal hernias

Official title: Prospective Trial of Posterior Rectus Sheath Hiatal Augmentation (PORSHA) in Paraesophageal Hernia Repair

Run by University of Chicago · NCT06551077 · Data updated 2026-11-12

This study is testing a new surgical method for fixing large paraesophageal hernias in older patients to see if it works better and lasts longer than traditional repairs.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity of Chicago
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedMay 15, 2024
Main results expectedMay 2029
Study endsMay 2029
Registry record updatedFebruary 2, 2026
Trial IDNCT06551077 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are older patients with paraesophageal hernias measuring greater than 4 cm.

Probably not a fit

Patients who do not undergo PoRSHA or those with bleeding disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on the use of a novel surgical technique called posterior rectus sheath flap hiatal augmentation (PoRSHA) for repairing challenging paraesophageal hernias in older patients. The approach utilizes the patient's own vascularized tissue to enhance the repair of the diaphragmatic hiatus, aiming to improve outcomes and durability compared to traditional methods. The study will observe patients undergoing this procedure to evaluate its effectiveness and safety in addressing large and recurrent hernias. The hypothesis is that PoRSHA can provide a stronger and more reliable repair than synthetic mesh or primary closure techniques.

Why it matters

Potential benefit: If successful, this technique could significantly improve surgical outcomes for patients with complex paraesophageal hernias.

How similar studies have gone: While this approach is innovative, it builds on existing techniques, and similar studies have shown promising outcomes with autologous tissue repairs.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients undergoing PoRSHA. PoRSHA will be offered to all patients with PEH defects measuring greater than 4 cm.

Exclusion Criteria:

* Patients that did not have PoRSHA.
* Patients requiring therapeutic anticoagulation perioperatively or those with bleeding disorders, considering the added risk of bleeding at the donor site with exposed rectus muscle.

Where it's running

  • The University of Chicago
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.